Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ROSENWALD LINDSAY A MD, holds the title of PRESIDENT, CEO & CHAIRMAN at Fortress Biotech, Inc..
On 2026-11-17, the insider transacted 136,723 shares.The shares were transacted at a weighted average price of $1.85 per share, resulting in a total market-relevant value of $253K.
ROSENWALD LINDSAY A MD (PRESIDENT, CEO & CHAIRMAN) bought $253K of $FBIO
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.